Addus HomeCare Co. (NASDAQ:ADUS) Sees Significant Increase in Short Interest

Addus HomeCare Co. (NASDAQ:ADUS) was the target of a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 548,700 shares, a growth of 36.5% from the September 15th total of 401,900 shares. Based on an average daily trading volume, of 131,900 shares, the short-interest ratio is currently 4.2 days.

Addus HomeCare Stock Performance

ADUS opened at $131.81 on Tuesday. The firm has a market cap of $2.39 billion, a P/E ratio of 32.71, a PEG ratio of 2.33 and a beta of 1.04. The firm has a 50-day moving average of $129.83 and a 200 day moving average of $117.54. Addus HomeCare has a fifty-two week low of $78.35 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. The business had revenue of $286.90 million for the quarter, compared to analysts’ expectations of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.94 EPS. Equities research analysts predict that Addus HomeCare will post 4.58 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on ADUS shares. Macquarie reiterated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Friday. Royal Bank of Canada reiterated an “outperform” rating and set a $141.00 price target on shares of Addus HomeCare in a report on Tuesday, September 3rd. KeyCorp started coverage on Addus HomeCare in a research note on Friday. They set an “overweight” rating and a $150.00 price objective on the stock. Stephens reiterated an “overweight” rating and issued a $138.00 target price on shares of Addus HomeCare in a research note on Tuesday, August 6th. Finally, Oppenheimer raised their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $131.38.

Insider Buying and Selling

In related news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares of the company’s stock, valued at $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the sale, the director now directly owns 3,366 shares of the company’s stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock valued at $3,050,082 over the last quarter. Insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. UMB Bank n.a. boosted its holdings in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares during the period. Quest Partners LLC bought a new position in Addus HomeCare in the 2nd quarter worth approximately $31,000. EntryPoint Capital LLC bought a new position in Addus HomeCare in the 1st quarter worth approximately $44,000. Innealta Capital LLC bought a new position in Addus HomeCare in the 2nd quarter worth approximately $44,000. Finally, GAMMA Investing LLC boosted its holdings in Addus HomeCare by 40.8% in the 1st quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after purchasing an additional 161 shares during the period. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.